Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
Dr Ingo Ringshausen | Wellcome-MRC Cambridge Stem Cell Institute
B6 - Ringshausen - Forschergruppe Prof. Dr. Oostendorp
NOTCH1 drives immune-escape mechanisms in B cell malignancies | bioRxiv
Dr Ingo Ringshausen | Wellcome-MRC Cambridge Stem Cell Institute
Spatial synthetic lethality- a new approach to treat B cell lymphoma (?)
Ingo Ringshausen on Twitter: "Excellent talk indeed!" / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
Guideline for the treatment of chronic lymphocytic leukaemia - Schuh - 2018 - British Journal of Haematology - Wiley Online Library
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
Dr Ingo Ringshausen - Department of Haematology
Frontiers | ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies
Ingo RINGSHAUSEN | University of Cambridge, Cambridge | Cam | Stem Cell Institute | Research profile
Ingo Ringshausen | Videos & Research | VJHemOnc
Loop | Ingo Ringshausen
Ingo RINGSHAUSEN | University of Cambridge, Cambridge | Cam | Stem Cell Institute | Research profile
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
Ingo Ringshausen (@i_ringshausen) / Twitter
Dr Ingo Ringshausen | Wellcome-MRC Cambridge Stem Cell Institute
